Back
Protagonist Therapeutics Vs. Trupanion Industry Stock Comparison
Buy
57
PTGX
Protagonist Therapeutics
Last Price:
33.37
Seasonality Move:
14.81%
Sell
43
TRUP
Trupanion
Last Price:
26.55
Seasonality Move:
15.13%
Buy
57
Protagonist Therapeutics (PTGX)
is a Buy
Is Protagonist Therapeutics a Buy, Sell or Hold?
- The current Protagonist Therapeutics [PTGX] share price is $34.35. The Score for PTGX is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
- PTGX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
43
Trupanion (TRUP)
is a Sell
Is Trupanion a Buy, Sell or Hold?
- The current Trupanion [TRUP] share price is $27.19. The Score for TRUP is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
- TRUP is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
PTGX Stock Price Chart
What is Protagonist Therapeutics's stock price today?
-
The Protagonist Therapeutics share price today is $34.35
The current trend is moderately bullish and PTGX is experiencing slight buying pressure.
TRUP Stock Price Chart
PTGX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.53 | Buy |
| Relative Strength Index (14 RSI): | 65.32 | Buy |
| Chaikin Money Flow: | 31807 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (28.84 - 33.28) | Buy |
| Bollinger Bands (100): | (25.93 - 30.91) | Buy |
TRUP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.32 | Buy |
| Relative Strength Index (14 RSI): | 47.31 | Sell |
| Chaikin Money Flow: | 37315 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (27.23 - 30.49) | Sell |
| Bollinger Bands (100): | (24.05 - 29.81) | Buy |
PTGX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 33.45 | Buy |
| 20-day SMA: | 31.48 | Buy |
| 50-day SMA: | 28.74 | Buy |
| 200-day SMA: | 23.52 | Buy |
| 8-day EMA: | 33.24 | Buy |
| 20-day EMA: | 31.6 | Buy |
| 50-day EMA: | 29.72 | Buy |
| 200-day EMA: | 25.34 | Buy |
TRUP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 28.28 | Sell |
| 20-day SMA: | 29.02 | Sell |
| 50-day SMA: | 26.16 | Buy |
| 200-day SMA: | 27.1 | Buy |
| 8-day EMA: | 28.09 | Sell |
| 20-day EMA: | 28.14 | Sell |
| 50-day EMA: | 27.32 | Sell |
| 200-day EMA: | 28.73 | Sell |
Protagonist Therapeutics Earnings Growth & PTGX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.10 per share, an increase next quarter of $2.69 per share, an increase this year of $4.32 per share, and a decrease next year of $2.45 per share.
Trupanion Earnings Growth & TRUP Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.36 per share, an increase next quarter of $0.03 per share, an increase this year of $0.96 per share, and an increase next year of $0.44 per share.
Protagonist Therapeutics Technical Analysis
| May 31 | Jun 3 | Jun 4 | Jun 5 | Jun 6 | Jun 7 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | Jun | |||||||||
| 31 | 03 | 04 | 05 | 06 | 07 | 10 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Trupanion Technical Analysis
| May 31 | Jun 3 | Jun 4 | Jun 5 | Jun 6 | Jun 7 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | Jun | |||||||||
| 31 | 03 | 04 | 05 | 06 | 07 | 10 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||